Camp4 Therapeutics (CAMP) Assets Average (2024 - 2026)
Camp4 Therapeutics recorded quarterly Assets Average of $111.6 million in Q1 2026, up 9.33% quarter-over-quarter from $102.1 million in Q4 2025, and up 58.25% year-over-year from $70.5 million in Q1 2025.
Camp4 Therapeutics' Assets Average history runs 3 years deep, the most recent figure standing at $111.6 million for Q1 2026.
- In Q1 2026, Assets Average rose 58.25% year-over-year to $111.6 million; the TTM figure through Mar 2026 stood at $111.6 million (up 58.25% YoY), while the FY2025 annual figure was $98.1 million, up 47.17% from the prior year.
- Assets Average came in at $111.6 million for Q1 2026 at Camp4 Therapeutics, up from $102.1 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $111.6 million in Q1 2026 to a low of $49.8 million in Q4 2024.
- A 3-year average of $76.7 million and a median of $69.7 million in 2025 frame the typical range for Assets Average.
- Across the five-year window, Assets Average jumped 104.88% in 2025 and soared 58.25% in 2026, its largest moves.
- Camp4 Therapeutics' Assets Average stood at $49.8 million in 2024, then soared by 104.88% to $102.1 million in 2025, then rose by 9.33% to $111.6 million in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $111.6 million, $102.1 million, and $68.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13.04 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 33.42 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.72 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 331.70 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 40.89 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 26.06 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 26.03 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 40.71 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 5.05 Bn |
| 10 | Camp4 Therapeutics | 245.89 Mn | 245.89 Mn | - | 111.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 111.63 Mn |
| Dec 31, 2025 | 102.10 Mn |
| Sep 30, 2025 | 68.84 Mn |
| Jun 30, 2025 | 57.02 Mn |
| Mar 31, 2025 | 70.54 Mn |
| Dec 31, 2024 | 49.84 Mn |